LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX)
CUSIP: 528872302
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 444,558,533
- Total 13F shares
- 288,616,985
- Share change
- -30,804,688
- Total reported value
- $453,067,592
- Put/Call ratio
- 29%
- Price per share
- $1.57
- Number of holders
- 134
- Value change
- -$48,604,221
- Number of buys
- 66
- Number of sells
- 33
Quarterly Holders Quick Answers
What is CUSIP 528872302?
CUSIP 528872302 identifies LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 528872302:
Top shareholders of LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Artal Group S.A. |
13F
|
Company |
39%
|
175,099,384
|
$294,166,966 | — | 30 Jun 2024 | |
| Siren, L.L.C. |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
35,402,689
|
$92,755,045 | — | 25 Jul 2024 | |
| FMR LLC |
13F
|
Company |
8.7%
|
38,687,123
|
$64,994,367 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.2%
|
9,890,153
|
$16,615,457 | — | 30 Jun 2024 | |
| BRAIDWELL LP |
13F
|
Company |
1.9%
|
8,294,950
|
$13,935,516 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.7%
|
7,675,125
|
$12,894,211 | — | 30 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.3%
|
5,846,100
|
$9,821,448 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.93%
|
4,121,191
|
$6,923,601 | — | 30 Jun 2024 | |
| Invus US Partners LLC |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
5,782,749
|
$6,090,969 | — | 05 Aug 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.73%
|
3,250,535
|
$5,461,876 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.54%
|
2,409,456
|
$4,047,886 | — | 30 Jun 2024 | |
| NEA Management Company, LLC |
13F
|
Company |
0.54%
|
2,382,286
|
$4,002,240 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.52%
|
2,313,477
|
$3,886,641 | — | 30 Jun 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.52%
|
2,304,150
|
$3,870,972 | — | 30 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.47%
|
2,092,710
|
$3,515,753 | — | 30 Jun 2024 | |
| Lonnel Coats |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
2,109,255
mixed-class rows
|
$3,507,748 | — | 28 Feb 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.13%
|
571,492
|
$3,236,254 | — | 30 Jun 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.42%
|
1,875,000
|
$3,150,000 | — | 30 Jun 2024 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.39%
|
1,715,831
|
$2,882,596 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.31%
|
1,359,148
|
$2,283,369 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.27%
|
1,190,448
|
$1,999,953 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.22%
|
997,528
|
$1,675,847 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.17%
|
738,628
|
$1,240,895 | — | 30 Jun 2024 | |
| Jeffrey L. Wade |
3/4/5
|
President and COO |
—
mixed-class rows
|
729,441
mixed-class rows
|
$1,106,796 | — | 08 Jul 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.13%
|
597,321
|
$1,003,499 | — | 30 Jun 2024 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.12%
|
542,899
|
$912,070 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
401,908
|
$675,206 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
373,431
|
$627,364 | — | 30 Jun 2024 | |
| B. Kassler Taub |
3/4/5
|
SVP, Regulatory & QA |
—
mixed-class rows
|
431,995
mixed-class rows
|
$597,845 | — | 28 Feb 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
354,036
|
$594,781 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.06%
|
273,041
|
$458,709 | — | 30 Jun 2024 | |
| BBR PARTNERS, LLC |
13F
|
Company |
0.06%
|
270,000
|
$453,600 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.05%
|
216,266
|
$363,328 | — | 30 Jun 2024 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.04%
|
179,972
|
$302,353 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
161,113
|
$270,670 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
152,785
|
$256,669 | — | 30 Jun 2024 | |
| Thomas Garner |
3/4/5
|
SVP, Chief Commercial Officer |
—
mixed-class rows
|
454,260
mixed-class rows
|
$239,236 | — | 08 Feb 2024 | |
| Robert J. Lefkowitz MD |
3/4/5
|
Director |
—
mixed-class rows
|
130,080
mixed-class rows
|
$223,156 | — | 13 May 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
129,856
|
$218,158 | — | 30 Jun 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.03%
|
121,986
|
$204,936 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.03%
|
117,179
|
$197,000 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
114,126
|
$191,732 | — | 30 Jun 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.02%
|
101,134
|
$170,000 | — | 30 Jun 2024 | |
| Lombard Odier SCmA Compagnie |
13F
|
Individual |
0.02%
|
94,000
|
$157,920 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
90,426
|
$151,915 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
87,185
|
$146,472 | — | 30 Jun 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.02%
|
84,637
|
$142,000 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
76,086
|
$127,824 | — | 30 Jun 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.02%
|
70,001
|
$125,302 | — | 30 Jun 2024 | |
| Ph.D. Kiernan Seth |
3/4/5
|
VP, Chief Commercial Officer |
—
mixed-class rows
|
379,163
mixed-class rows
|
$104,343 | — | 28 Feb 2023 |
Institutional Holders of LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) as of Q3 2024
As of 30 Sep 2024,
LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) was held by
134 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
288,616,985 shares.
The largest 10 holders included
Artal Group S.A., FMR LLC, Siren, L.L.C., ORBIMED ADVISORS LLC, BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NEA Management Company, LLC, and AMERIPRISE FINANCIAL INC.
This page lists
134
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
121
Q3 2024 holders
134
Holder diff
13
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.